Electrosurgical Devices Market Analysis

Electrosurgery is the use of high energy alternating current to increase intracellular temperature to achieve vaporization or combination of desiccation and protein coagulation of biological tissue. Electrosurgical devices find application in general surgery, cardiology, urology, gynecology, cosmetology, and dermatology domains.

The global electrosurgical devices market is estimated to account for US$ 6,087.3 Mn in terms of value in 2020 and is expected to reach US$ 9,677.6 Mn by the end of 2027.

Global Electrosurgical Devices Market: Drivers

Increasing demand for minimally invasive surgeries is expected to propel growth of the global electrosurgical devices market over the forecast period. Electrosurgical devices have been widely used for minimal invasive surgeries in the field of gynecology, cosmetology, open surgery, laparoscopic procedures, and flexible endoscopic procedures. Minimally-invasive surgeries entail shorter hospital stay, minimal incision, less post-surgery complications, and shorter recovery time. These advantages attract patients and help increase the number of patients opting for minimally invasive surgeries.

Moreover, increasing geriatric population is also expected to boost demand for electrosurgical devices. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.     

General Surgery held dominant position in the global electrosurgical devices market in 2019, accounting for 31.0% share in terms of value, followed by Gynaecology and Cardiology, respectively.

Figure 1. Global Electrosurgical Devices Market Share (%), by Value, by Application, 2019

Global Electrosurgical Devices Market: Restraints

Stringent regulatory requirements for device approvals and product recalls are expected to hinder growth of the global electrosurgical devices market.

Moreover, complications of electrosurgery are also expected to limit the market growth. Electrosurgery is associated with several electro-thermal injuries that may result from its application, insulation failure, direct coupling, capacitive coupling, and other modes.

Electrosurgical Devices Market Report Coverage

Report Coverage	Details
Base Year:	2019	Market Size in 2019:	US$ 5,698.4 Mn
Historical Data for:	2016 to 2019	Forecast Period:	2020 to 2027
Forecast Period 2020 to 2027 CAGR:	6.8%	2027 Value Projection:	US$ 9,677.6 Mn
Geographies covered:	North America: U.S., Canada Latin America: Brazil, Argentina, Mexico, Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, Rest of Asia Pacific Middle East: GCC Countries, Israel, Rest of Middle East Africa: South Africa, North Africa, Central Africa
Segments covered:	By Product Type: Radiofrequency Electrosurgical Devices: Monopolar Devices, Bipolar Devices. Electrocautery Devices: Monopolar Devices, Bipolar Devices. Electrosurgical Accessories By Application: General surgery, Gynecology, Cardiology, Urology, Dermatology & Cosmetology, Others. By End User: Hospitals, ASC’s, Specialized Clinics.
Companies covered:	Bovie Medical Corporation, Medtronic Plc, BOWA-Electronic GmbH & Co. KG, KLS Martin, B. Braun Melsungen AG, Conmed, Olympus Corp., Boston Scientific Corporation, Erbe Elektromedizin GmbH, Symmetry Surgical Inc., Encision Inc., Gala Therapeutics, Inc., Apyx Medical Corporation, and Johnson & Johnson Services, Inc.
Growth Drivers:	Technological advancement. Increasing number of surgeries.
Restraints & Challenges:	Stringent regulatory requirements

Global Electrosurgical Devices Market: Opportunities 

Increasing adoption of less invasive techniques in cosmetology surgeries is expected to offer lucrative growth opportunities for players in the global electrosurgical devices market. Preference has shifted from traditional open surgery to usage of less invasive techniques. Electrosurgical devices have been widely used to perform surgeries such as neck lift, forehead lift, chin surgery, liposuction, and abdominoplasty.

Moreover, increasing prevalence of cancer is also expected to boost demand for electrosurgical devices. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.  

The global electrosurgical devices market was valued at US$ 5,698.4 Mn in 2019 and is forecast to reach a value of US$ 9,677.6 Mn by 2027 at a CAGR of 6.8% between 2020 and 2027.

Figure 2. Global Electrosurgical Devices Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

Market Trends/Key Takeaways

Major players in the global electrosurgical devices market are focused on adopting partnership strategies to enhance their market share. For instance, in July 2020, Lexington Medical, a US-based medical device company, partnered with BOWA Medical. Under the partnership, the companies will jointly market and sell the AEON and LOTUS portfolios in several global markets.

Major players in the market are also focused on approval and launch of new products to expand their product portfolio. For instance, in September 2019, Gala Therapeutics, Inc. received CE Mark in the European Union for its RheOx system that delivers non-thermal energy to the airways in a minimally invasive procedure called Bronchial Rheoplasty to reduce mucus-producing cells in patients with chronic bronchitis.

Regulations

U.S.

• FDA has developed this guidance document to assist industry in preparing premarket notification (510(k)) submissions for electrosurgical devices intended for use in general surgery. These devices are designed to cut and/or remove tissue and control bleeding through the use of high- frequency electrical current. For the purpose of this guidance, electrosurgical devices may also be called radiofrequency (RF) devices or high- frequency (HF) devices.
• There are other medical devices that have been classified under other medical panels which come under section 872.4920, 876.4300, 882.4400, 884.4150, 886.4100, 886.4115

Europe

• Devices classified under rule 9 are the active therapeutic devices intended to administer or exchange energy. Devices classified by this rule are mostly electrical equipment used in surgery such as lasers and surgical generators. In addition there are devices for specialized treatment such as radiation treatment.
• High-frequency electrosurgical generators, and electrocautery equipment, including their electrodes are counted under Class Iib with a CE marking

Global Electrosurgical Devices Market: Competitive Landscape

Major players operating in the global electrosurgical devices market include, Bovie Medical Corporation, Medtronic Plc, BOWA-Electronic GmbH & Co. KG, KLS Martin, B. Braun Melsungen AG, Conmed, Olympus Corp., Boston Scientific Corporation, Erbe Elektromedizin GmbH, Symmetry Surgical Inc., Encision Inc., Gala Therapeutics, Inc., Apyx Medical Corporation, and Johnson & Johnson Services, Inc.

Global Electrosurgical Devices Market: Key Developments

Major players in the global electrosurgical devices market are focused on approval and launch of new products to expand their product portfolio. For instance, in August 2020, Encision Inc., a developer of Active Electrode Monitoring Technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, launched AEM 2X enTouch Scissors.

Similarly, in October 2019, Apyx Medical Corporation received U.S. Food and Drug Administration (FDA) 510(k) clearance to market and sell the Apyx Plasma/RF Handpiece, a new addition to the Renuvion product family.